Israel Englander Chemo Centryx, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $13.6 Million - $31.8 Million	613,117 Added 165.4%	983,809 $50.8 Million
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $14.3 Million - $25.6 Million	-930,257 Reduced 71.51%	370,692 $9.19 Million
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $1.62 Million - $2.85 Million	72,725 Added 5.92%	1,300,949 $32.6 Million
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $17.4 Million - $38.3 Million	946,776 Added 336.39%	1,228,224 $44.7 Million
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $2.13 Million - $3.2 Million	161,521 Added 134.68%	281,448 $4.81 Million
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $723,210 - $3.84 Million	75,413 Added 169.41%	119,927 $1.61 Million
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $2.2 Million - $3.04 Million	44,514 New	44,514 $2.28 Million
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $4.4 Million - $6.06 Million	-93,056 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $5.97 Million - $7.94 Million	-128,776 Reduced 58.05%	93,056 $5.1 Million
Q2 2020 Aug 14, 2020	SELL	$38.58 - $65.07 $5.15 Million - $8.68 Million	-133,399 Reduced 37.55%	221,832 $12.8 Million
Q1 2020 May 14, 2020	SELL	$32.73 - $50.78 $646,515 - $1 Million	-19,753 Reduced 5.27%	355,231 $14.3 Million
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $334,881 - $1.94 Million	-49,175 Reduced 11.59%	374,984 $14.8 Million
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $1.9 Million - $2.63 Million	293,420 Added 224.43%	424,159 $2.88 Million
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $672,503 - $1.2 Million	80,927 Added 162.46%	130,739 $984,000
Q1 2019 May 14, 2019	BUY	$10.01 - $13.89 $330,319 - $458,356	32,999 Added 196.27%	49,812 $692,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $1.66 Million - $2.22 Million	-181,037 Reduced 91.5%	16,813 $183,000
Q3 2018 Nov 14, 2018	SELL	$10.49 - $13.72 $1.99 Million - $2.61 Million	-190,025 Reduced 48.99%	197,850 $2.5 Million
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $677,163 - $891,406	63,763 Added 19.67%	387,875 $5.11 Million
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $402,857 - $1.02 Million	68,281 Added 26.69%	324,112 $4.41 Million
Q4 2017 Feb 14, 2018	BUY	$5.53 - $8.42 $204,991 - $312,120	37,069 Added 16.94%	255,831 $1.52 Million
Q3 2017 Nov 14, 2017	BUY	$6.5 - $10.69 $1.42 Million - $2.34 Million	218,762	218,762 $1.62 Million

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account